Authors
Loading...
In vitro study demonstrates high-efficiency CRISPR delivery via silicon nanoneedles in human induced pluripotent stem cells, highlighting an effective platform for isogenic organoid disease modeling.
Ghani et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: